Superworth

National Vision PE ratio EYE

Share price divided by earnings per share over the last twelve months, since 2018.

Today, Nov 2, 2026
28.1×
8-year median
52.7×
Against its 8-year history
14th
percentile: 0 is its lowest day, 100 its highest
8-year range
20.3× to 334×
Peer median
34.8×

National Vision's PE ratio is 28.1× as of Nov 2, 2026: a share price of $17.13 against $0.61 of earnings per share over the last twelve months.

That is below its 8-year median of 52.7×, lower than on 86% of days in the last 8 years.

Over that time it ranged from 20.3× in Jun 2022 to 334× in Jan 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 34.8×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far28.1×26.9×75.4×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
202353.3×35.4×70.5×
202257.9×20.3×61.1×
202127.1×26.2×125×
2020103×35.1×334×
2019301×29.2×301×
201830.5×27.8×50.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.

CompanyPE ratio
EYENational Vision28.1×
CDRECadre38.9×
STAAStaar Surgical356×
BVSBioventus17.1×
IARTIntegra Lifesciences80.1×
IRMDIradimed42.5×
LMATLemaitre Vascular28.5×
INSPInspire Medical Systems14.5×
UFPTUFP Technologies30.6×
MOVMovado17.7×
WRBYWarby Parker341×
Peer median34.8×

Where National Vision ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on National Vision

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.